보고서 요약(국문)

개요
글로벌 조직학 및 세포학 소모품 시장은 2022년 XX백만 달러에 도달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) XX%로 성장하여 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
조직학 소모품은 플러그 앤 플레이 방식의 전용 소모품을 통해 품질을 향상시키고 오류를 줄이며 시간을 절약해 줍니다. 유리 슬라이드와 커버슬립부터 왁스 및 대량 시약에 이르기까지, 모든 실험실의 원활한 운영은 고품질 소모품의 안정적인 공급에 달려 있습니다. 세포학은 세포의 형태, 구조, 미세 구조, 생활 주기 및 병리를 다루는 생물학의 한 분야입니다. 역사적으로 세포학은 세포와 세포 구조의 미세한 모습을 연구하는 학문, 특히 이상 및 악성 종양 진단을 위한 학문으로 여겨져 왔습니다.

시장 동향: 성장 동력 및 제약 요인
주요 기업들의 전략
주요 기업들은 현대 조직병리학 실험실의 가장 까다로운 요구 사항을 충족하기 위해 새로운 해부병리학 소모품 출시와 관련하여 투자, 확장, 협력 및 파트너십을 확대해 왔습니다.
예를 들어, 맥키니에 본사를 둔 의료 진단 용품 개발 및 제조업체인 StatLab Medical Products는 2021년과 2022년에 영국에 기반을 둔 조직병리학 소모품 및 진단 장비 회사 두 곳을 인수한 후 2023년 7월 알링턴에 새로운 제조 시설을 설립했습니다. 35,000평방피트 규모의 이 새로운 알링턴 시설에서 이루어지는 사출 성형 작업은 카세트를 포함한 추가적인 미국산 핵심 조직병리학 소모품에 대한 실험실의 신뢰를 높여줄 것입니다.

향후 StatLab은 아카이빙 서비스를 출시하여 조직학 소모품 시장의 선두 주자로서의 입지를 더욱 공고히 할 뿐만 아니라, 연구실에 샘플 아카이빙을 위한 포괄적인 오프사이트 솔루션을 제공하여 필요할 때 샘플을 보관하고 검색할 수 있도록 함으로써 귀중한 시간과 저장 공간을 절약할 수 있도록 할 계획입니다.
또한, 조기 질병 발견 및 진단을 위한 연구 개발 수요 증가, 의료비 지출 증가, 병원 및 진단 연구실 증가, 맞춤형 의약품 수요 증가로 인해 개별 세포 구조 및 기능 연구가 필수적이며, 암 및 자가면역 질환과 같은 세포 기반 질환의 유병률 증가로 특정 세포 및 조직의 검출 및 진단이 요구되고 있습니다.
시장 동향: 제약 요인
조직학 및 세포학 관련 엄격한 정부 규제 정책과 복잡한 절차는 예측 기간 동안 전 세계 조직학 및 세포학 시장의 성장을 저해할 것으로 예상되는 요인입니다. 예를 들어, 2021년 5월 미국 국립생명공학정보센터(NCBI)에서 발표한 기사에 따르면, 조직학적 검체 슬라이드 제작에는 고정, 탈수, 포매, 절편 제작 등 여러 단계가 포함되며, 이는 복잡하고 시간이 많이 소요되는 작업입니다.
보고서에 대한 자세한 내용은 샘플을 요청하십시오.
세그먼트 분석
전 세계 조직학 및 세포학 소모품 시장은 제품 유형, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 세그먼트에서 조직학 및 세포학 염색약 및 염료 세그먼트는 조직학 및 세포학 소모품 시장 점유율의 약 43.5%를 차지했습니다.
제품 유형 세그먼트에서 삼중 조직학 및 세포학 소모품 세그먼트는 약 43.5%를 차지했으며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 조직학 및 세포학 검사 과정에는 조직 샘플 용기, 키트, 염색 시약, 고정액, 배지 시약 및 기타 시약과 같은 여러 소모품이 사용됩니다. 이 시장 부문의 큰 비중은 주로 조직학 및 세포학 소모품의 일상적인 사용에 기인합니다.
예를 들어, 슬라이드 염색 및 세포 원심분리기 기술의 선구자이자 혁신 기업으로 세계적으로 인정받는 ELITechGroup Inc.는 35년 동안 Aerospray 염색 기술을 개발하며 약 30개의 특허를 보유하고 있으며, 2020년 3월에는 Aerospray 세포학 슬라이드 염색기 겸 세포 원심분리기를 출시했습니다.

지리적 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 높은 암 발병률, FDA 승인, 활발한 연구 개발 활동, 주요 업체들의 존재, 그리고 병리학 서비스 연구 인프라 구축 등의 요인으로 인해 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 또한, 이 지역의 높은 제품 승인 및 상용화율은 조직학 및 세포학 시장의 성장에 더욱 기여하고 있습니다.
예를 들어, 2023년 4월, 다나허(Danaher)의 라이카 바이오시스템즈(Leica Biosystems)는 대장암(CRC) 환자를 대상으로 린치 증후군 가능성을 선별 검사하는 고객에게 고성능 면역조직화학(IHC) 불일치 복구(MMR) 검사 기회를 제공하는 Bond MMR 항체 패널에 대한 미국 FDA 승인을 발표했습니다. 이처럼 다양한 제품 출시를 통해 진단 목적의 조직 및 세포 선별 검사가 효율적으로 이루어지고 있습니다.

또한, 2021년 4월, Sakura Finetek USA, Inc.는 조직학 실험실의 조직 고정, 처리 및 염색 요구 사항을 충족하는 일관되고 신뢰할 수 있으며 고품질의 시약을 완벽하게 제공하는 Tissue-Tek 조직학 시약 제품군을 출시했다고 발표했습니다.
“새로운 Tissue-Tek 조직학 시약 제품군은 Tissue-Tek VIP 시리즈 조직 처리기 및 Tissue-Tek Prisma 시리즈 자동 슬라이드 염색 시스템에 사용되는 소모품 제품 포트폴리오를 완성합니다.
COVID-19 영향 분석
COVID-19 팬데믹은 조직학 및 세포학 시장 성장에 긍정적인 영향을 미쳤습니다. 면역조직화학 검증을 위한 특정 항체 개발을 위해 여러 기업 간의 전략적 협력이 이루어졌습니다. 예를 들어, 2020년 9월 GeneTex, Inc.는 HistoWiz, Inc.와 협력하여 인간 COVID-19 감염 조직의 면역조직화학에 사용할 수 있는 다양한 검증된 항체를 개발했습니다.
시장 세분화
제품 유형별
• 조직학 및 세포학 염색약 및 염료
• 조직학 및 세포학 키트 및 시약
• 조직학 및 세포학 효소
• 기타
응용 분야별
• 분자 진단
• 세포 신호 전달
• 임상 진단
• 후성유전학 및 시퀀싱 연구
• 기타
최종 사용자별
• 병원
• 진단 센터
• 학술 연구 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 이탈리아
o 스페인
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
시장의 주요 글로벌 업체로는 Thermo Fisher Scientific, Inc., Leica Biosystems, Becton Dickinson and Company, Hoffmann-La Roche Ltd., Hologics, Merck, Trivitron Healthcare, Cardinal Health, Hospitex International Srl, CellPath 등이 있습니다.
주요 개발 사항
 2023년 2월, BioReference Health LLC는 CINtec을 제공하는 최초의 상업용 연구소 중 하나가 될 것이라고 발표했습니다. 로슈 진단(Roche Diagnostics)의 PLUS 세포진 검사. CINtec PLUS 세포진 검사는 고위험 인유두종바이러스(HPV) 양성 판정을 받은 환자를 위한 유일한 FDA 승인 이중 염색 선별 검사입니다.
 2022년 12월, 세계적인 생명과학 기업인 랩코프(Labcorp)는 로스앤젤레스에 새롭고 더 큰 규모의 해부병리 및 조직학(APH) 연구소 운영을 시작하여 회사의 글로벌 중앙 연구소 역량을 확장했다고 발표했습니다.
 2022년 7월, 나노스틱스(Nanostics Inc.)는 자사의 Clarity DX 진단 플랫폼을 사용하여 새롭고 최소 침습적인 방광암 진단 검사인 Clarity DX Bladder를 검증하기 위한 전향적 임상 연구를 시작했습니다.

보고서 구매 이유:

• 제품 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 조직학 및 세포학 소모품 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악합니다.

• 트렌드 및 공동 개발 분석을 통해 상업적 기회를 식별합니다.

• 다양한 데이터 포인트가 포함된 Excel 데이터 시트 제공 조직학 및 세포학 소모품 시장 전체 부문 분석

• PDF 보고서는 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석 자료입니다.

• 주요 업체들의 핵심 제품을 포함한 제품 맵핑 자료는 엑셀 파일로 제공됩니다.

글로벌 조직학 및 세포학 소모품 시장 보고서는 약 77개의 표, 79개의 그림, 187페이지 분량입니다.
주요 독자층 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Histology and Cytology Consumables Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX % during the forecast period 2023-2030.
Histology consumables improve quality, reduce errors, and save time with dedicated plug-and-play consumables. From glass slides and coverslips to wax and bulk reagents, the smooth running of any laboratory depends on a consistent supply of high-quality consumables. Whereas Cytology is the branch of biology dealing with the morphology, structure, ultrastructure, life cycle, and pathology of cells. Historically cytology has referred to the study of the microscopic appearance of cells and cell structures, especially for the diagnosis of abnormalities and malignancies.
Market Dynamics: Drivers and Restraints
Strategies adopted by the key companies
The key companies have increased their investments, expansion, collaborations and partnerships in the release of novel anatomical pathology consumables to meet the most demanding demands of contemporary histology laboratories.
For instance, in July 2023, StatLab Medical Products, a McKinney-based developer and manufacturer of medical diagnostic supplies, launched a new manufacturing facility in Arlington after acquiring two UK-based histology consumables and diagnostic equipment companies in 2021 and 2022. Injection molding operations at the new 35,000-square-foot Arlington facility will give laboratories confidence in additional U.S.-produced core histology consumables including cassettes.
In the future company plans to launch of archiving service that not only will cement StatLab as a market leader in the histology consumables market, but also provide laboratories with a comprehensive off-site solution for sample archiving, allowing them to be stored and retrieved when needed, saving valuable time and storage space.
Furthermore, increased demand for research and development for early disease detection and diagnosis, increased healthcare spending. An increase in hospitals and diagnostic laboratories, and increased demand for personalized medicines necessitates the study of individual cell structure and function, an increase in the prevalence of cell-based diseases such as cancer and autoimmune diseases requires the detection and diagnosis of specific cells and tissue.
Market Dynamics: Restraint
The stringent government regulations policies and complicated procedures associated with histology and cytology are the factors that are expected to hinder growth of the global histology and cytology market over the forecast period. For instance, according to an article published by the National Center for Biotechnology Information (NCBI) in May 2021, histological specimen slide preparation involves a number of steps such as fixation, dehydration, embedding, sectioning, and others which can prove to be a complicated and time-consuming task.
For more details of the report- Request for sample
Segment Analysis
The global histology and cytology consumables market is segmented based on product type, application, end-user and region.
The histology and cytology stains and dyes segment from the product type segment accounted for approximately 43.5% of the histology and cytology consumables market share
The triple histology and cytology consumables segment from the product type segment accounted for approximately 43.5% and is expected to be dominated during the forecast period. Several consumables are used for the histology and cytology process such as tissue sample containers, kits, stain reagents, fixative solutions, medium reagents, and other reagents. The large share of the segment can be primarily attributed to the routine adoption of histology and cytology consumables.
For instance, in March 2020, ELITechGroup Inc., recognized worldwide as slide staining and cytocentrifuge technologic pioneers and innovators, with nearly 30 patents, over the 35-year lifespan of Aerospray staining technology, stated the launch of the Aerospray Cytology Slide Stainer Cytocentrifuge.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the factors like high incidences of cancer, FDA clearance, extensive R&D activities, presence of key players, and established research infrastructure for pathology services. In addition, the high rate of product approval and commercialization in the region is further contributing to the growth of the market for histology and cytology.
For instance, in April 2023, Danaher’s Leica Biosystems announced the U.S. FDA clearance for its Bond MMR Antibody Panel, which offers a high-performing immunohistochemistry (IHC) mismatch repair (MMR) opportunity for clients that are screening colorectal cancer (CRC) individuals for probable Lynch syndrome. The various launches for efficient screening of tissues and cells for diagnostic purposes.
Moreover, in April 2021, Sakura Finetek USA, Inc. stated the launch of the Tissue-Tek Histology Reagents, delivering a full complement of consistent, reliable and high-quality reagents to meet the tissue fixation, processing, and staining needs of histology laboratories.
“The new line of Tissue-Tek Histology Reagents completes our product portfolio of consumables for use on our Tissue-Tek VIP Series of tissue processors and Tissue-Tek Prisma Series automated slide staining systems.
COVID-19 Impact Analysis
The COVID-19 pandemic had a positive impact on the growth of the market for histology and cytology. Various strategic collaborations were observed between the companies for developing antibodies specific for validation with immunohistochemistry. For instance, in September 2020, GeneTex, Inc. partnered with HistoWiz, Inc. to establish various validated antibodies for immunohistochemistry in human COVID-19-infected tissues.
Market Segmentation
By Product Type
• Histology and Cytology Stains and Dyes
• Histology and Cytology Kits and Reagents
• Histology and Cytology Enzymes
• Others
By Application
• Molecular Diagnostics
• Cell Signaling
• Clinical Diagnosis
• Epigenetics and Sequencing Study
• Others
By End User
• Hospitals
• Diagnostic Centers
• Academic Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Thermo Fisher Scientific, Inc., Leica Biosystems, Becton Dickinson and Company., Hoffmann-La Roche Ltd., Hologics, Merck, Trivitron Healthcare, Cardinal Health, Hospitex International Srl, CellPath and among others.
Key Developments
 In February 2023, BioReference Health LLC announced it would be one of the first commercial laboratories to offer the CINtec PLUS Cytology test from Roche Diagnostics. CINtec PLUS Cytology is the only FDA-approved dual-stain triage test for patients who have a positive high-risk human papillomavirus (HPV) result.
 In December 2022, Labcorp a leading global life sciences company, announced that it has begun operations at a new, larger anatomic pathology and histology (APH) laboratory in Los Angeles, expanding the company’s global central laboratory capabilities.
 In July 2022, Nanostics Inc. launched a prospective clinical study to validate a novel and minimally invasive bladder cancer diagnostic test, Clarity DX Bladder, using its Clarity DX diagnostic platform.
Why Purchase the Report?
• To visualize the global histology and cytology consumables market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analysing trends and co-development.
• Excel data sheet with numerous data points of histology and cytology consumables market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global histology and cytology consumables market report would provide approximately 77 tables, 79 figures and 187 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Market Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Strategies adopted by the key companies
4.1.1.2. Rise in the prevalence of chronic diseases
4.1.2. Restraints
4.1.2.1. Stringent government regulations policies
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Unmet Needs
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Histology and Cytology Stains and Dyes*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Histology and Cytology Enzymes
7.4. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Molecular Diagnostics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cell Signaling
8.4. Clinical Diagnosis
8.5. Epigenetics and Sequencing Study
8.6. Others
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Centers
9.4. Academic Research Institutes
9.5. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.5.1. China
10.5.5.2. India
10.5.5.3. Japan
10.5.5.4. Australia
10.5.5.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Thermo Fisher Scientific, Inc*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Leica Biosystems
12.3. Becton Dickinson and Company.
12.4. Hoffmann-La Roche Ltd.
12.5. Hologics
12.6. Merck
12.7. Trivitron Healthcare
12.8. Cardinal Health
12.9. Hospitex International Srl
12.10. CellPath
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific, Inc, 4.	Key Developments, Leica Biosystems, Becton Dickinson and Company., Hoffmann-La Roche Ltd., Hologics, Merck, Trivitron Healthcare, Cardinal Health, Hospitex International Srl, CellPath

표 목록 (Tables)

List of Tables

Table 1 Global Histology and Cytology Consumables Market Value, By Product Type, 2023, 2027 & 2031(US$ Million)

Table 2 Global Histology and Cytology Consumables Market Value, By Application, 2023, 2027 & 2031(US$ Million)

Table 3 Global Histology and Cytology Consumables Market Value, By End User, 2023, 2027 & 2031(US$ Million)

Table 4 Global Histology and Cytology Consumables Market Value, By Region, 2023, 2027 & 2031(US$ Million)

Table 5 Global Histology and Cytology Consumables Market Value, By Product Type, 2023, 2027 & 2031(US$ Million)

Table 6 Global Histology and Cytology Consumables Market Value, By Product Type, 2022-2031(US$ Million)

Table 7 Global Histology and Cytology Consumables Market Value, By Application, 2023, 2027 & 2031(US$ Million)

Table 8 Global Histology and Cytology Consumables Market Value, By Application, 2022-2031(US$ Million)

Table 9 Global Histology and Cytology Consumables Market Value, By End User, 2023, 2027 & 2031(US$ Million)

Table 10 Global Histology and Cytology Consumables Market Value, By End User, 2022-2031(US$ Million)

Table 11 Global Histology and Cytology Consumables Market Value, By Region, 2023, 2027 & 2031(US$ Million)

Table 12 Global Histology and Cytology Consumables Market Value, By Region, 2022-2031(US$ Million)

Table 13 North America Histology and Cytology Consumables Market Value, By Product Type, 2022-2031(US$ Million)

Table 14 North America Histology and Cytology Consumables Market Value, By Application, 2022-2031(US$ Million)

Table 15 North America Histology and Cytology Consumables Market Value, By End User, 2022-2031(US$ Million)

Table 16 North America Histology and Cytology Consumables Market Value, By Country, 2022-2031(US$ Million)

Table 17 South America Histology and Cytology Consumables Market Value, By Product Type, 2022-2031(US$ Million)

Table 18 South America Histology and Cytology Consumables Market Value, By Application, 2022-2031(US$ Million)

Table 19 South America Histology and Cytology Consumables Market Value, By End User, 2022-2031(US$ Million)

Table 20 South America Histology and Cytology Consumables Market Value, By Country, 2022-2031(US$ Million)

Table 21 Europe Histology and Cytology Consumables Market Value, By Product Type, 2022-2031(US$ Million)

Table 22 Europe Histology and Cytology Consumables Market Value, By Application, 2022-2031(US$ Million)

Table 23 Europe Histology and Cytology Consumables Market Value, By End User, 2022-2031(US$ Million)

Table 24 Europe Histology and Cytology Consumables Market Value, By Country, 2022-2031(US$ Million)

Table 25 Asia-Pacific Histology and Cytology Consumables Market Value, By Product Type, 2022-2031(US$ Million)

Table 26 Asia-Pacific Histology and Cytology Consumables Market Value, By Application, 2022-2031(US$ Million)

Table 27 Asia-Pacific Histology and Cytology Consumables Market Value, By End User, 2022-2031(US$ Million)

Table 28 Asia-Pacific Histology and Cytology Consumables Market Value, By Country, 2022-2031(US$ Million)

Table 29 Middle East & Africa Histology and Cytology Consumables Market Value, By Product Type, 2022-2031(US$ Million)

Table 30 Middle East & Africa Histology and Cytology Consumables Market Value, By Application, 2022-2031(US$ Million)

Table 31 Middle East & Africa Histology and Cytology Consumables Market Value, By End User, 2022-2031(US$ Million)

Table 32 Thermo Fisher Scientific, Inc.: Overview

Table 33 Thermo Fisher Scientific, Inc.: Product Portfolio

Table 34 Thermo Fisher Scientific, Inc.: Key Developments

Table 35 Leicabiosystems: Overview

Table 36 Leicabiosystems: Product Portfolio

Table 37 Leicabiosystems: Key Developments

Table 38 Becton Dickinson and Company.: Overview

Table 39 Becton Dickinson and Company.: Product Portfolio

Table 40 Becton Dickinson and Company.: Key Developments

Table 41 Hoffmann-La Roche Ltd.: Overview

Table 42 Hoffmann-La Roche Ltd.: Product Portfolio

Table 43 Hoffmann-La Roche Ltd.: Key Developments

Table 44 Hologics: Overview

Table 45 Hologics: Product Portfolio

Table 46 Hologics: Key Developments

Table 47 Merck: Overview

Table 48 Merck: Product Portfolio

Table 49 Merck: Key Developments

Table 50 Trivitron Healthcare: Overview

Table 51 Trivitron Healthcare: Product Portfolio

Table 52 Trivitron Healthcare: Key Developments

Table 53 Cardinal Health: Overview

Table 54 Cardinal Health: Product Portfolio

Table 55 Cardinal Health: Key Developments

Table 56 Hospitex International Srl: Overview

Table 57 Hospitex International Srl: Product Portfolio

Table 58 Hospitex International Srl: Key Developments

Table 59 CellPath: Overview

Table 60 CellPath: Product Portfolio

Table 61 CellPath: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 2 Global Histology and Cytology Consumables Market Share, By Product Type, 2022 & 2031(%)

Figure 3 Global Histology and Cytology Consumables Market Share, By Application, 2022 & 2031(%)

Figure 4 Global Histology and Cytology Consumables Market Share, By End User, 2022 & 2031(%)

Figure 5 Global Histology and Cytology Consumables Market Share, By Region, 2022 & 2031(%)

Figure 6 Global Histology and Cytology Consumables Market Y-o-Y Growth, By Product Type, 2022-2031(%)

Figure 7 Histology and Cytology Kits and Reagents Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 8 Histology and Cytology Enzymes Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 9 Histology and Cytology Stains and Dyes Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 10 Others Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 11 Global Histology and Cytology Consumables Market Y-o-Y Growth, By Application, 2022-2031(%)

Figure 12 Molecular Diagnostic Study Application in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 13 Cell Signaling Application in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 14 Clinical Diagnosis Application in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 15 Epigenetics and Sequencing Study Application in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 16 Others Application in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 17 Global Histology and Cytology Consumables Market Y-o-Y Growth, By End User, 2022-2031(%)

Figure 18 Hospitals End User in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 19 Diagnostic Centers End User in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 20 Academic Research Institutes End User in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 21 Others End User in Global Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 22 Global Histology and Cytology Consumables Market Y-o-Y Growth, By Region, 2022-2031(%)

Figure 23 North America Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 24 Asia-Pacific Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 25 Europe Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 26 South America Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 27 Middle East and Africa Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 28 North America Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 29 North America Histology and Cytology Consumables Market Share, By Product Type, 2022 & 2031(%)

Figure 30 North America Histology and Cytology Consumables Market Share, By Application, 2022 & 2031(%)

Figure 31 North America Histology and Cytology Consumables Market Share, By End User, 2022 & 2031(%)

Figure 32 North America Histology and Cytology Consumables Market Share, By Country, 2022 & 2031(%)

Figure 33 South America Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 34 South America Histology and Cytology Consumables Market Share, By Product Type, 2022 & 2031(%)

Figure 35 South America Histology and Cytology Consumables Market Share, By Application, 2022 & 2031(%)

Figure 36 South America Histology and Cytology Consumables Market Share, By End User, 2022 & 2031(%)

Figure 37 South America Histology and Cytology Consumables Market Share, By Country, 2022 & 2031(%)

Figure 38 Europe Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 39 Europe Histology and Cytology Consumables Market Share, By Product Type, 2022 & 2031(%)

Figure 40 Europe Histology and Cytology Consumables Market Share, By Application, 2022 & 2031(%)

Figure 41 Europe Histology and Cytology Consumables Market Share, By End User, 2022 & 2031(%)

Figure 42 Europe Histology and Cytology Consumables Market Share, By Country, 2022 & 2031(%)

Figure 43 Asia-Pacific Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 44 Asia-Pacific Histology and Cytology Consumables Market Share, By Product Type, 2022 & 2031(%)

Figure 45 Asia-Pacific Histology and Cytology Consumables Market Share, By Application, 2022 & 2031(%)

Figure 46 Asia-Pacific Histology and Cytology Consumables Market Share, By End User, 2022 & 2031(%)

Figure 47 Asia-Pacific Histology and Cytology Consumables Market Share, By Country, 2022 & 2031(%)

Figure 48 Middle East & Africa Histology and Cytology Consumables Market Value, 2022-2031(US$ Million)

Figure 49 Middle East & Africa Histology and Cytology Consumables Market Share, By Product Type, 2022 & 2031(%)

Figure 50 Middle East & Africa Histology and Cytology Consumables Market Share, By Application, 2022 & 2031(%)

Figure 51 Middle East & Africa Histology and Cytology Consumables Market Share, By End User, 2022 & 2031(%)

Figure 52 Thermo Fisher Scientific, Inc.: Financials

Figure 53 Leicabiosystems: Financials

Figure 54 Becton Dickinson and Company.: Financials

Figure 55 Hoffmann-La Roche Ltd.: Financials

Figure 56 Hologics: Financials

Figure 57 Merck: Financials

Figure 58 Trivitron Healthcare: Financials

Figure 59 Cardinal Health: Financials

Figure 60 Hospitex International Srl: Financials

Figure 61 CellPath: Financials

세계 조직학 및 세포학 소모품 시장 – 2023-2030

Global Histology and Cytology Consumables Market - 2023-2030